Search

everythinglearnresearchcommunity

for

Search:↓

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

The new 5% minoxidil foam is as effective and safe as Rogaine® for treating hair loss in Chinese men.

Immune activities and specific genes are important in male pattern baldness.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

PRP injections are not effective for long-term treatment of temporal triangular alopecia.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

PRP is a promising treatment for autoimmune hair loss but its exact workings are not fully understood.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Microneedles help treat hair loss by improving hair surroundings and promoting growth.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Hair loss in women links to inflammation around hair follicles.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

EGFR inhibitors can cause yellowish skin eruptions.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

A new microneedle patch effectively promotes hair growth by increasing blood vessel formation around hair follicles.

Minoxidil increased small openings in blood vessel walls near growing hair in rats.

The scalp has a natural speckled pattern of increased pigment around hair follicles, possibly linked to local hormone production.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.